47 Matching Annotations
  1. Last 7 days
  2. Aug 2024
  3. Jul 2024
    1. RRID:AB_2617169

      DOI: 10.1111/bph.16487

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @scibot

      SciCrunch record: RRID:AB_2617169


      What is this?

  4. Jun 2024
  5. Apr 2024
  6. Mar 2024
  7. Dec 2023
  8. Oct 2023
  9. Aug 2023
  10. Apr 2022
  11. Feb 2022
  12. Aug 2021
    1. AB_2617169

      DOI: 10.1210/en.2016-1700

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @scibot

      SciCrunch record: RRID:AB_2617169


      What is this?

    1. RRID:AB_2617169

      DOI: 10.1016/j.celrep.2021.109490

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @scibot

      SciCrunch record: RRID:AB_2617169


      What is this?

    1. RRID:AB_2617169

      DOI: 10.1016/j.cmet.2018.10.007

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @scibot

      SciCrunch record: RRID:AB_2617169


      What is this?

  13. Jul 2021
    1. AB_2617169u00a0

      DOI: 10.1210/en.2016-1583

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @Jmenke

      SciCrunch record: RRID:AB_2617169


      What is this?

    2. DAKO (A056401, AB_2617169)

      DOI: 10.1210/en.2016-1583

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @Jmenke

      SciCrunch record: RRID:AB_2617169


      What is this?

  14. May 2021
  15. Apr 2021
    1. RRID: AB_2617169

      DOI: 10.1016/j.devcel.2021.02.011

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @bandrow

      SciCrunch record: RRID:AB_2617169


      What is this?

    2. AB_2617169

      DOI: 10.1016/j.devcel.2021.02.011

      Resource: (Agilent Cat# A056401-2, RRID:AB_2617169)

      Curator: @scibot

      SciCrunch record: RRID:AB_2617169


      What is this?

  16. Jan 2021
  17. Nov 2020
  18. Sep 2020
  19. May 2020
    1. Initial screening for insulin, MHC class I, and CD8. For characterization of the sections before tetramer staining, staining for insulin, CD8, and HLA-ABC (all at room temperature) was performed using the antibodies listed in Table 3. Fixation was with acetone and sections were blocked with goat serum in a standard immunofluorescent staining protocol. An islet was determined as hyperexpressing MHC class I based on a threshold of three unequivocally positive cells, which was the maximum number found in all control islets examined.Table 3.Antibodies used for characterization of the sections prior to tetramer stainingAntigenPrimary antibodyDetection antibodyInsulinPolyclonal guinea pig anti-insulin (Dako; 1/140 dilution, 1-h incubation)Polyclonal goat anti–guinea pig IgG, highly cross-adsorbed, Alexa Fluor 488 (Invitrogen; 1/1000 dilution, 30-min incubation)HLA-ABCMouse monoclonal (clone W6/32) IgG2a against a monomorphic epitope on the 45 kD polypeptide products of the HLA-A, B and C loci (Dako; 1/100 dilution, 1 h incubation)Polyclonal goat anti–mouse IgG2a, isotype-specific, Alexa Fluor 594 (Invitrogen; 1/1000 dilution, 30-min incubation)CD8Mouse monoclonal (clone HIT8a) IgG1 against the CD8 alpha subunit (BD; 1/100 dilution, 1-h incubation)F(ab’)2 fragment of goat anti-mouse IgG, Alexa Fluor 594 (Invitrogen; 1/1000 dilution, 30-min incubation)

      Initial screening for insulin, MHC class I, and CD8

  20. Jan 2020
  21. Nov 2018
  22. Nov 2017